Phase 3 Startnegative~month

Phase 3 Start: A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Mu

Drug
ndv-01
Indication
Urothelial Carcinoma Bladder; Urothelial Carcinoma Recurrent; Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)

Other upcoming events for RLMD

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study Evaluating the Efficacy and Safety of NDV-01 in Participants With Non-muscle Invasiv

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Start: A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Mu — RLMD Phase 3 Start | BioSniper